These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17589943

  • 1. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.
    Miyanaka Y, Ueno Y, Tanaka S, Yoshioka K, Hatakeyama T, Shimamoto M, Sumii M, Chayama K.
    World J Gastroenterol; 2007 Jun 07; 13(21):2939-44. PubMed ID: 17589943
    [Abstract] [Full Text] [Related]

  • 2. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH.
    Inflamm Bowel Dis; 2015 Feb 07; 21(2):241-50. PubMed ID: 25545374
    [Abstract] [Full Text] [Related]

  • 3. [Correlations Between the Expression of MicroRNA-155 and Suppressor of Cytokine Signaling 1 in Colonic Mucosal Tissue and Disease Severity in Patients With Ulcerative Colitis].
    Zhang X, Jia HY, Song WX, Zhao HQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Jun 07; 46(3):334-340. PubMed ID: 38953257
    [Abstract] [Full Text] [Related]

  • 4. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ.
    Gut; 2010 Feb 07; 59(2):227-35. PubMed ID: 19926618
    [Abstract] [Full Text] [Related]

  • 5. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
    Li Y, Nuij VJ, Baars JE, Biermann K, Kuipers EJ, Peppelenbosch MP, de Haar C, Janneke van der Woude C.
    Inflamm Bowel Dis; 2013 Jan 07; 19(1):132-40. PubMed ID: 22535619
    [Abstract] [Full Text] [Related]

  • 6. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R, Koide T, Tokoro C, Yamamoto T, Godai T, Morohashi T, Fujita Y, Takahashi D, Kawana I, Suzuki S, Umemura S.
    Inflamm Bowel Dis; 2009 Mar 07; 15(3):328-34. PubMed ID: 18942752
    [Abstract] [Full Text] [Related]

  • 7. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis.
    Hozumi H, Hokari R, Kurihara C, Narimatsu K, Sato H, Sato S, Ueda T, Higashiyama M, Okada Y, Watanabe C, Komoto S, Tomita K, Kawaguchi A, Nagao S, Miura S.
    Int J Colorectal Dis; 2013 Aug 07; 28(8):1049-55. PubMed ID: 23377880
    [Abstract] [Full Text] [Related]

  • 8. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
    Wang YD, Yan PY.
    World J Gastroenterol; 2006 Oct 07; 12(37):6050-3. PubMed ID: 17009408
    [Abstract] [Full Text] [Related]

  • 9. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.
    Pathak S, Grillo AR, Scarpa M, Brun P, D'Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G, Sturniolo GC, Buda A, Castagliuolo I.
    Exp Mol Med; 2015 May 22; 47(5):e164. PubMed ID: 25998827
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Cytokine and Efflux Transporter Expression in Pediatric Versus Adult-onset Ulcerative Colitis.
    Savić Mlakar A, Hojsak I, Jergović M, Vojvoda Parčina V, Babić Ž, Troskot B, Mihaljević Ž, Bendelja K.
    J Pediatr Gastroenterol Nutr; 2017 Jun 22; 64(6):943-948. PubMed ID: 27622899
    [Abstract] [Full Text] [Related]

  • 11. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
    Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.
    Carcinogenesis; 2012 Oct 22; 33(10):1889-96. PubMed ID: 22739025
    [Abstract] [Full Text] [Related]

  • 12. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J, Vanhove W, Lemaire K, Van Lommel L, Machiels K, Wollants WJ, De Preter V, De Hertogh G, Ferrante M, Van Assche G, Rutgeerts P, Schuit F, Vermeire S, Arijs I.
    PLoS One; 2014 Oct 22; 9(12):e116117. PubMed ID: 25546151
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
    Valmiki S, Ahuja V, Paul J.
    World J Gastroenterol; 2017 Aug 07; 23(29):5324-5332. PubMed ID: 28839432
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y, Ishihara S, Kawashima K, Fukuba N, Sonoyama H, Kusunoki R, Oka A, Mishima Y, Oshima N, Moriyama I, Yuki T, Ishikawa N, Araki A, Harada Y, Maruyama R, Kinoshita Y.
    J Gastroenterol Hepatol; 2016 Aug 07; 31(8):1443-52. PubMed ID: 26676714
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
    Planell N, Lozano JJ, Mora-Buch R, Masamunt MC, Jimeno M, Ordás I, Esteller M, Ricart E, Piqué JM, Panés J, Salas A.
    Gut; 2013 Jul 07; 62(7):967-76. PubMed ID: 23135761
    [Abstract] [Full Text] [Related]

  • 16. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N.
    Am J Gastroenterol; 2002 Nov 07; 97(11):2820-8. PubMed ID: 12425554
    [Abstract] [Full Text] [Related]

  • 17. A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
    Diab J, Al-Mahdi R, Gouveia-Figueira S, Hansen T, Jensen E, Goll R, Moritz T, Florholmen J, Forsdahl G.
    Inflamm Bowel Dis; 2019 Feb 21; 25(3):490-497. PubMed ID: 30476077
    [Abstract] [Full Text] [Related]

  • 18. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3.
    Park SJ, Kim TH, Jun YJ, Lee SH, Ryu HY, Jung KJ, Jung JY, Hwang GH, Lee SH.
    J Allergy Clin Immunol; 2013 Mar 21; 131(3):772-80. PubMed ID: 23375208
    [Abstract] [Full Text] [Related]

  • 19. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.
    Toiyama Y, Mizoguchi A, Kimura K, Araki T, Yoshiyama S, Sakaguchi K, Miki C, Kusunoki M.
    World J Gastroenterol; 2005 Sep 07; 11(33):5151-5. PubMed ID: 16127744
    [Abstract] [Full Text] [Related]

  • 20. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
    Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.
    Mol Med; 2012 Dec 20; 18(1):1412-9. PubMed ID: 23154639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.